JAPAC Drug Development: Navigating Safety & Regulatory Requirements
HIT Consultant
APRIL 15, 2024
Director of Regulatory Affairs and Drug Development Solutions, IQVIA Asia Pacific The biopharmaceutical market within the Japan and Asia-Pacific (JAPAC) region has grown consistently since 2010, specifically for emerging biopharmas (EBPs). This team works together to maintain quality and compliance for an organization.
Let's personalize your content